SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 10 SUPPL., 1997, Pages

Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies

(2) Quay, Steven C a Eisenfeld, Amy J a

a Sonus Pharmaceuticals (United States)

Author keywords

Adverse effects; Contrast agent; EchoGen ; Perflenapent emulsion; Safety

Indexed keywords

ALBUNEX; PERFLUOROPENTANE; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DRUG INDUCED DISEASE; DRUG RESEARCH; DRUG SAFETY; DRUG USE; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIODIAGNOSIS;

EID: 0030717565 PISSN: 01609289 EISSN: None Source Type: Journal
DOI: 10.1002/clc.4960201306 Document Type: Article

Times cited : (7)

References (8)

1
- 0030057698
- ® emulsion: A new ultrasound contrast agent based on phase shift colloids
- ® emulsion: A new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996;51:11-41
- (1996) Clin Radiol , vol.51 , pp. 11-41
- Correas, J.-M.¹ Quay, S.C.²

2
- 9844258967
- USA; Patent numbers 5,409,688; 5,393,524; 5,573,751; 5,558,853; 5,558,854;5,558,094;5,595,723; SONUS Pharmaceuticals, 1995, 1996
- Quay SC: USA; Patent numbers 5,409,688; 5,393,524; 5,573,751; 5,558,853; 5,558,854;5,558,094;5,595,723; SONUS Pharmaceuticals, 1995, 1996
- Quay, S.C.¹

3
- 0002760036
- The first phase shift ultrasound contrast agent: EchoGen
- (Ed. Goldberg B), London: Martin Dunitz
- Correas J-M, Kessler D, Woran D, Quay SC: The first phase shift ultrasound contrast agent: EchoGen. In Ultrasound Contrast Agents (Ed. Goldberg B), p. 101-120. London: Martin Dunitz, 1997
- (1997) Ultrasound Contrast Agents , pp. 101-120
- Correas, J.-M.¹ Kessler, D.² Woran, D.³ Quay, S.C.⁴

4
- 0037714470
- Ionic and nonionic contrast media: Current status and controversies
- Amin M, Cohan R, Dunnick N: Ionic and nonionic contrast media: Current status and controversies. Appl Radiol 1993;22(11):41-54
- (1993) Appl Radiol , vol.22 , Issue.11 , pp. 41-54
- Amin, M.¹ Cohan, R.² Dunnick, N.³

5
- 0023250447
- Nephrotoxicity of common drugs used in clinical practice
- Cooper K, Bennett W: Nephrotoxicity of common drugs used in clinical practice. Arch Intern Med 1987;147:1213-1218
- (1987) Arch Intern Med , vol.147 , pp. 1213-1218
- Cooper, K.¹ Bennett, W.²

6
- 0021173968
- Newer contrast agents for urography
- Spataro R: Newer contrast agents for urography. Radiol Clin North Am 1984;22:365-380
- (1984) Radiol Clin North Am , vol.22 , pp. 365-380
- Spataro, R.¹

7
- 0027429973
- Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex multicenter trial
- Crouse L, Cheirif J, Hanly D, Kisslo J, Labovitz A, Raichlen J, Schutz R, Shaw P, Smith M: Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex multicenter trial. J Am Coll Cardiol 1993;22(5):1494-1500
- (1993) J Am Coll Cardiol , vol.22 , Issue.5 , pp. 1494-1500
- Crouse, L.¹ Cheirif, J.² Hanly, D.³ Kisslo, J.⁴ Labovitz, A.⁵ Raichlen, J.⁶ Schutz, R.⁷ Shaw, P.⁸ Smith, M.⁹

8
- 0030094504
- Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system
- Eckholm S, Jonsson E, Sandvik L, Fagerlund M, Holtas S, Isberg B, Lindell D, Linden B, Sjoberg S, Thuomas K-Å, Tollesson P: Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system. Acta Radiol 1996;37:223-228
- (1996) Acta Radiol , vol.37 , pp. 223-228
- Eckholm, S.¹ Jonsson, E.² Sandvik, L.³ Fagerlund, M.⁴ Holtas, S.⁵ Isberg, B.⁶ Lindell, D.⁷ Linden, B.⁸ Sjoberg, S.⁹ Thuomas, K.-Å.¹⁰ Tollesson, P.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.